Back to CVE records
Critical 9.8Published Aug 26, 2026

CVE-2026-80428ILIAS PHP Object Injection via Shibboleth Logout

Updated under an hour ago ()

Does this affect you?

It affects ILIAS-eLearning e.V. ILIAS. Add what you run to find out whether that includes you.

No exploitation reported and no EPSS estimate yet.

ILIAS before versions 9.22, 10.10, and 11.3 contains an unauthenticated PHP object injection vulnerability that allows unauthenticated attackers to execute arbitrary code by injecting serialized objects through the LTI authentication endpoint and triggering deserialization via the Shibboleth back-channel logout endpoint. Attackers can write arbitrary serialized objects into session storage, then exploit an available POP gadget through the logout endpoint's unrestricted deserialization to write attacker-controlled PHP content to a web-accessible path and achieve remote code execution as the web server user.

CVSS
9.8 CRITICAL (v3.1, CNA)CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H
Weakness (CWE)
CWE-502
Known exploited
Not in CISA's KEV catalog
EPSS (exploitation in the next 30 days)
Not loaded for this CVE
Assigned by
VulnCheck
NVD analysis
Awaiting Analysis
Record last updated
Sep 30, 2026
First seen by InfoSec Signals
Oct 9, 2026

Affected products

Affected products
ILIAS-eLearning e.V. ILIAS
ilias_elearning_e.v:ilias (from the name)
from 9.0 before 9.22; from 10.0 before 10.10; from 11.0 before 11.3
CNA record

References

  • release-notes
  • patch, product
  • release-notes
  • product, patch
  • release-notes
  • product, patch
  • technical-description
  • technical-description, exploit

The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.

Your cookie choices
We use essential cookies to run this site, and, only with your consent, an advertising cookie from Google to measure whether our ads lead to sign-ups and subscriptions. See our for details.